Reports, Notices, Documents

Notice of Adoption to Text of Regulations Title 27, California Code of Regulations Amendment to Section 25805 Maximum Allowable Dose Level (MADL) for Avermectin B1

10/26/2011

Extension of Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/24/2011

Carcinogen Identification Committee Meeting Scheduled for October 12 and 13, 2011

10/12/2011

Notice of Augmentation of Record and 2nd Modification of Text of Proposed Regulation Title 22, California Code of Regulations, Sections 69401 Through 69407 Green Chemistry Hazard Traits for California’s Toxics Information Clearinghouse

10/07/2011

Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/07/2011

Comment Period - Changed Notice of Proposed Rulemaking Specific Regulatory Levels Posing No Significant Risk: 4-Methylimidazole (4-MEI)

10/07/2011

Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

09/23/2011

Comment Period - Proposed Amendment To Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

09/23/2011

Notice of Withdrawal and Resubmittal of Proposed Rulemaking Amendment to Section 25705 Specific Regulatory Levels Posing No Significant Risk: Imazalil

09/23/2011

Comments on Proposed Modified Regulation

09/22/2011